Fig. 4From: Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectivesLung tumors induce cDC anergy through different pathways. Tumors can alter the molecular expression of DC and also upregulate the immunosuppression miRNAs in DCs to inhibit the secretion of IL-12. Exosomes secreted by lung tumor cells can induce PD-L1 expression in DCs. Furthermore, different factors (HMGB1, TSLP, lactic acid) are highly expressed in lung tumors, and these may interact with different pathways within DCs to achieve a tumor-supportive microenvironment. cDC: conventional DC; HMGB1: high mobility group box-1 protein; TSLP: thymic stromal lymphopoietin; TSLPR: thymic stromal lymphopoietin receptor; IFN-γ: interferon γ; STING: stimulator of IFN genes; TLR2: toll-like receptor 2; Treg: regulatory T cells; PD-L1: programmed cell death 1 ligand 1; IL-10R: interleukin 10 receptor; TIM3: T-cell immunoglobulin and mucin-domain 3Back to article page